Equity - Stock Options (Details) $ / shares in Units, $ in Millions |
3 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
Aug. 31, 2016
item
$ / shares
shares
|
Dec. 31, 2025
USD ($)
shares
|
Dec. 31, 2024
USD ($)
shares
|
Dec. 31, 2023
USD ($)
shares
|
Sep. 30, 2022
USD ($)
shares
|
Dec. 31, 2025
USD ($)
shares
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
shares
|
Dec. 31, 2022
shares
|
|
| EQUITY | |||||||||
| Options granted | 937,424 | ||||||||
| Option exercise price (per share) | $ / shares | $ 5.34 | ||||||||
| Number of executives | item | 2 | ||||||||
| Number of share options distributed as non-cash and stock dividend | 12,034 | ||||||||
| Options outstanding, intrinsic value | $ | $ 2.7 | $ 2.7 | |||||||
| Compensation costs | $ | 17.6 | $ 17.5 | $ 12.9 | ||||||
| Employee Stock Option | |||||||||
| EQUITY | |||||||||
| Expiration period | 10 years | ||||||||
| Options exercised | 20,000 | ||||||||
| Options exercised, intrinsic value | $ | $ 0.8 | $ 0.6 | $ 2.6 | $ 0.1 | |||||
| Balance options | 917,424 | ||||||||
| Compensation costs | $ | $ 0.0 | $ 0.0 | $ 0.0 | ||||||
| Employee Stock Option | Class A Common Stock | |||||||||
| EQUITY | |||||||||
| Options exercised | 150,000 | 100,000 | 168,712 | ||||||
| Options outstanding and unexercised | 498,712 | 748,712 | 498,712 | 748,712 | |||||
| Employee Stock Option | Class B Common Stock | |||||||||
| EQUITY | |||||||||
| Options granted | 183,484 | ||||||||
| Options exercised | 30,000 | 20,000 | 33,742 | ||||||
| Options outstanding and unexercised | 108,697 | 149,742 | 108,697 | 149,742 | |||||
| X | ||||||||||
- Definition Number of executives. No definition available.
|
| X | ||||||||||
- Definition The number of share options distributed as non-cash and stock dividend during the period. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|